Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Savolitinib and docetaxel in advanced gastric adenocarcinoma
NCT02447406Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Apr 2015
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of savolitinib in gastric adenocarcinoma, sponsored by Samsung Medical Center. Started Apr 2015; status: completed.
02
Drugs
savolitinib
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT02447406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02447406.